Stocktoria
Axogen, Inc. AXGN
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1986-12-17
Axogen, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 74.3% | 75.8% | 76.6% | 78.5% | 82.0% |
| Operating margin | -3.5% | -1.8% | -13.5% | -21.4% | -20.0% |
| Net margin | -7.0% | -5.3% | -13.7% | -20.9% | -21.2% |
| FCF margin | -1.3% | 0.8% | -12.3% | -26.1% | -32.4% |
| Return on assets | -7.1% | -4.9% | -11.0% | -14.8% | -13.0% |
| Return on equity | -12.2% | -9.6% | -22.7% | -28.7% | -24.0% |
| Debt / equity | 0.38× | 0.46× | 0.49× | 0.45× | 0.40× |
| Current ratio | 5.11 | 3.24 | 2.89 | 4.13 | 5.23 |
| Revenue growth | 20.2% | 17.8% | 14.7% | 8.8% | 13.4% |
Source: SEC EDGAR filings · CIK 0000805928 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.